AKT1 and glioblastoma: These compounds could potentially prevent malignant glioblastoma proliferation by negatively regulating phosphodiesterase-4, extracellular signal-regulated kinase, Akt/mammalian target of rapamycin kinase, and nuclear factor kappa-light-chain-enhancer of activated B cells.[55]